| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 07/08/2004 | US20040131545 Anticholesterol agents |
| 07/08/2004 | US20040131544 Positron emission tomography ; multistage process; medical diagnosis |
| 07/08/2004 | US20040131543 Radiopharmaceuticals and radioactive microspheres for locoregional ablation of abnormal tissues |
| 07/08/2004 | DE19744003B4 Kontrastmittel für das Infarkt- und Nekroseimaging Contrast agents for infarction and necrosis |
| 07/08/2004 | DE10252390A1 Verfahren zur Bestimmung der Funktionsfähigkeit der Bauchspeicheldrüse Methods for determining the functionality of the pancreas |
| 07/08/2004 | CA2509418A1 Isotope labeled camptothecin derivatives |
| 07/07/2004 | EP1434802A1 Human tissue factor antibodies |
| 07/07/2004 | EP1434801A2 Treatment for central nervous system disorders |
| 07/07/2004 | EP1434604A2 4-haloethenylphenyl tropane:serotonin transporter imaging agents |
| 07/07/2004 | EP1434592A1 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer |
| 07/07/2004 | EP1434578A1 Arylsulphonyl-substituted tetrahydro- and hexahydro-carbazoles as 5-ht-6 receptor ligands |
| 07/07/2004 | EP1434571A1 Particle immobilized coatings and uses thereof |
| 07/07/2004 | EP1045675A4 In-situ radioactive stent |
| 07/07/2004 | CN1510036A Tween induced technetium-99m isonitrile complex, two-stage isonitrile medicinal box and its use |
| 07/07/2004 | CN1156492C Somatostatin peptides |
| 07/07/2004 | CN1156445C Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isindoline derivatives |
| 07/06/2004 | US6759406 Quaternary ammonium compounds |
| 07/06/2004 | US6759403 Metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 07/06/2004 | US6759045 Administering antibodies; anticancer agents |
| 07/06/2004 | US6759028 Treating arteriovenous malformations by use of radioactive compositions; in vivo delivery of radioactive compositions which are delivered as a fluid to one or more vascular sites and solidified |
| 07/01/2004 | WO2004055026A1 Tetracyclic 3-substituted indoles having serotonin receptor affinity |
| 07/01/2004 | WO2004054615A1 Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent |
| 07/01/2004 | WO2004026111A3 Flexible and/or elastic brachytherapy seed or strand |
| 07/01/2004 | WO2004024878A3 Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 07/01/2004 | WO2004017905A3 Method and apparatus for noninvasively evaluating endothelial function |
| 07/01/2004 | WO2004004635A3 Radiolabeled compounds and liposomes and their methods of making and using the same |
| 07/01/2004 | WO2003074992A3 Phosphorylated proteins and uses related thereto |
| 07/01/2004 | US20040126758 homologous to the known fibrinogen derived haptotactic peptides; shown to elicit activity from fibroblasts, endothelial and smooth muscle cells; for wound healing and enhancing osteogenesis/angiogenesis in vivo with/without medical implant |
| 07/01/2004 | US20040126317 Skeletal-targeted radiation to treat bone-associated pathologies |
| 07/01/2004 | CA2549463A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands |
| 07/01/2004 | CA2509103A1 Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent |
| 06/30/2004 | EP1432453A1 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 06/30/2004 | EP0977600B1 Contrast agents targetting receptors associated with angiogenesis |
| 06/30/2004 | CN1509188A Immunoconjugates made of egg-yolk antibiodies (IGY), production and use thereof in diagnoses and therapy |
| 06/29/2004 | US6756481 IL-23 receptor binding compositions |
| 06/29/2004 | CA2031518C Endothelial cell-leukocyte adhesion molecules (elams) and molecules involved in leukocyte adhesion (milas) |
| 06/24/2004 | WO2004052408A1 Radioablation of hemolymphopoietic cell populations |
| 06/24/2004 | WO2004052357A1 Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases |
| 06/24/2004 | US20040122279 Sterile radioactive seeds |
| 06/24/2004 | US20040120958 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 06/24/2004 | US20040120893 human monoclonal antibody fragment (Fab), cloned by phage display that binds specifically to oxidized forms of low density lipoproteins (OxLDL) and not native LDL; use of the antibody for methods of diagnosis and treatment of atherosclerosis |
| 06/24/2004 | US20040120892 stabilizers for radiopharmaceutical compositions which are added after radiolabeling but prior to administration; Ascorbic acid and/or a derivative thereof, is used to inhibit oxidation loss and autoradiolysis of radiolabeled peptides and proteins |
| 06/24/2004 | US20040120890 Rhenium-188 and rhenium-186 for treatment of tumors expressing a Na+/I- symporter |
| 06/24/2004 | DE10256900A1 Tumorspezifische Erkennungsmoleküle Tumor-specific recognition molecules |
| 06/24/2004 | CA2509328A1 Radioablation of hemolymphopoietic cell populations |
| 06/24/2004 | CA2508663A1 Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases |
| 06/23/2004 | EP1431311A1 Immunotherapy of B-cell malignancies using anti-CD22 and anti-CD20 antibodies in combination |
| 06/23/2004 | EP1430071A1 Secreted and cell surface genes expressed in benign and malignant colorectal tumors |
| 06/23/2004 | EP1429797A2 Diagnosis and treatment of malignant neoplasms |
| 06/23/2004 | EP1429783A2 Multi-use multimodal imaging chelates |
| 06/23/2004 | EP1429776A2 Tricyclic indole derivatives as 5-ht ligands |
| 06/23/2004 | EP1429665A2 Composite staple for completing an anastomosis |
| 06/23/2004 | EP0785804B1 Liposomal agents |
| 06/23/2004 | CN1506372A Isonitrile compound for radioactive Tc-99m label and its prepn and application |
| 06/23/2004 | CN1154635C Novel compounds with analgesic effect |
| 06/23/2004 | CN1154508C Stimulation of host defence mechanisms against viral challenges |
| 06/23/2004 | CN1154494C Adenosine A3 receptor modulators |
| 06/23/2004 | CN1154483C Use of amines to produce drugs for preventing tumour cell proliferation |
| 06/22/2004 | US6753160 Method of using metaloporphyrins for treatment of arteriosclerotic lesions |
| 06/22/2004 | CA2172455C Labelled compound |
| 06/17/2004 | WO2004050707A2 Tumor-specific recognition molecules |
| 06/17/2004 | WO2004050698A2 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 06/17/2004 | WO2004050168A2 Radiopharmaceuticals and radioactive microspheres for locoregional ablation of abnormal tissues |
| 06/17/2004 | WO2004049907A2 Compositions and methods for treating transplants |
| 06/17/2004 | WO2004017907A3 Blood clot-targeted nanoparticles |
| 06/17/2004 | WO2004003155A3 Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors |
| 06/17/2004 | WO2003033648A3 Imaging the activity of extracellular proteases in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases |
| 06/17/2004 | US20040116703 Central nervous system disorders, nicotinic acetylcholine receptors; endocrine diseases; antiinflammatory agents; analgesics; drug dependency; skin disorders; Alzheimer's and Parkinson's disease |
| 06/17/2004 | US20040116387 thyroid receptor ligands, preferably antagonists for the treatment of cardiac and metabolic disorders, such as cardiac arrhythmias, thyrotoxicosis, subcllinical hyperthyrodism and liver diseases |
| 06/17/2004 | US20040115207 targeting agent conjugated to a diagnostically or therapeutically effective agent by a metabolizable linker moiety, which is cleaved by an exogenous enzyme; targeting agent may be an antibody and the agent may be a radioisotope |
| 06/17/2004 | US20040115205 Use of antibodies against the MUC18 antigen |
| 06/17/2004 | US20040115131 Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body |
| 06/17/2004 | US20040115128 Targeting endothelium for tissue-specific delivery of agents |
| 06/16/2004 | WO2004054978A1 Quinoline derivative as diagnostic probe for disease with tau protein accumulation |
| 06/16/2004 | EP1428821A1 Piperidin-4-yl amines with analgesic effect |
| 06/16/2004 | EP1427377A2 Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate specific membrane antigen |
| 06/16/2004 | EP1427325A2 Management of gastro-intestinal disorders |
| 06/16/2004 | EP0847530B1 QUANTITATION OF p97 TO DIAGNOSE AND MONITOR ALZHEIMER'S DISEASE |
| 06/16/2004 | CN1504472A Technetium-99m marked isonitrile group mating material, preparing process and uses thereof |
| 06/16/2004 | CN1153572C Mineral salt composition and its use |
| 06/16/2004 | CA2465554A1 Quinoline derivatives as probes for the diagnosis of diseases in which tau protein accumulates |
| 06/15/2004 | US6750340 Bisphosphonate conjugates and methods of making and using the same |
| 06/15/2004 | US6750323 Platelet activation protein |
| 06/15/2004 | US6750037 Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques |
| 06/15/2004 | US6749853 Combined methods and compositions for coagulation and tumor treatment |
| 06/15/2004 | US6749845 Modulated release particles for lung delivery |
| 06/15/2004 | US6749832 Labelled ascorbic acid derivatives |
| 06/15/2004 | CA2109256C Technetium or rhenium-binding bi-hapten derivatives, a process for their preparation, diagnostic and therapeutic application, and kits and immunological reagents containing same |
| 06/15/2004 | CA2086426C Process for the preparation of transition metal nitrido complexes |
| 06/10/2004 | WO2004035093A3 Polymeric materials for site specific delivery to the body |
| 06/10/2004 | WO2004013285A3 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 06/10/2004 | WO2003013617A3 Conjugates of macrocyclic metal complexes with biomolecules and the utilization thereof for producing agents for use in nmr diagnosis and radiodiagnosis and radiotherapy |
| 06/10/2004 | US20040110746 Piperazinyl and diazapanyl benzamides and benzthioamides |
| 06/10/2004 | US20040110723 Modified psma ligands and uses related thereto |
| 06/10/2004 | US20040109866 Immonotherapy complex containing antigen, antibodies, epitopes; binding to receptors |
| 06/10/2004 | US20040109823 Flexible and/or elastic brachytherapy seed or strand |
| 06/09/2004 | EP1426063A2 Formable integral source material for medical and industrial devices |
| 06/09/2004 | EP1426062A2 Radiolabeled annexins |
| 06/09/2004 | EP1425306A2 Nanoparticles comprising biologically active tnf which is immobilised on the same |
| 06/09/2004 | EP1425067A2 Radioactive implantable devices and methods and apparatuses for their production and use |